Zenith Health Care: 2018 Amalgamation Plan, Key Details

Company snapshot and why it is in focus

Zenith Health Care Ltd is engaged in manufacturing pharmaceutical products such as tablets, capsules, ointments, and liquid injectables, among others. The company is linked to Zenith Healthcare Limited (ZHL), described as a listed public limited company managed by a professional Chartered Accountant for 20 years. The corporate presence is anchored in Ahmedabad, Gujarat, which is positioned in the text as being near a leading pharmaceutical hub in India. Alongside the business overview, attention is drawn to a proposed amalgamation process involving group entities and to a more recent quarterly result update.

What the company makes

The product mix mentioned for Zenith Health Care Ltd spans multiple dosage forms, including tablets, capsules, ointments, and liquid injectable products. This matters because these categories typically imply different manufacturing lines and compliance requirements across solid, topical, and sterile formats. The information provided does not specify therapeutic segments, customer mix, or export exposure. It also does not provide capacity numbers or regulatory approvals. Still, the manufacturing scope indicates the company operates across more than one formulation type.

Registered office, works, and contact footprint

The registered and corporate office is listed at 504, Iscon Elegance, near Shapath 5, S.G. Road, Ahmedabad-380015, Gujarat. Multiple contact points are provided, including email IDs and phone numbers. A works address is mentioned at 388/34, Changodar Industrial Estate, Sarkhej-Bawla Highway, Changodar-382213, District Ahmedabad, with associated phone and fax details. The text also includes an agent information address in Marol, Andheri (East), Mumbai-400059, Maharashtra, with board and fax numbers.

Market cap and listed-company identifiers

A market capitalisation figure of ₹20 crore is provided in the supplied content. The parent organisation is stated as Zenith Healthcare Limited. The website is listed as http://www.zenithhealthcare.com. Beyond these identifiers, the text does not provide the company’s NSE/BSE ticker, share price, or free float details. It also does not specify promoter holding or debt levels.

Amalgamation proposal: entities involved

The content references an application for amalgamation involving Zenith Healthcare Limited (ZHL) as the transferee company and Zenith Medicine Pvt. Ltd. (ZMPL) as the transferor company. No ratio, appointed date, or scheme details are included in the material provided. There are also no stated regulatory steps beyond the board-level consideration. As presented, this is an early-stage disclosure focused on process initiation and board review.

Board meeting disclosure dated 19 October 2018

Zenith Health Care Ltd informed BSE that a meeting of the Board of Directors was scheduled on 19/10/2018. The stated purpose included considering and approving the notice of the company’s 4th Board Meeting of the Directors (04/2018-19). The agenda also included considering the proposal for amalgamation. The text does not provide the board’s eventual decision, voting outcome, or subsequent filings.

Quarterly result update: June 2025

The supplied update states that Zenith Health Care reported a net loss of ₹0.02 crore in the quarter ended June 2025. This is compared with a net profit of ₹0.16 crore during the previous quarter, as per the snippet provided. The item is timestamped “12 Aug 2025 16:30” in the text. No revenue, EBITDA, margin, or cash flow details are provided alongside this profit and loss comparison.

Institutional or fund holding snippet: what is shown

The content includes a line stating it is a list of major funds holding the stock as of the last reported quarter, followed by a table header with fields such as Scheme Name, AUM (%), CMV (in Cr.), and Holding Date. One visible row shows “Aditya Birla Nuvo Ltd” with “35.67” repeated across the columns presented. The provided excerpt does not include other schemes, the specific quarter, or a complete dataset. Based on the text alone, it can only be treated as a partial and incomplete snapshot.

Key facts table

How to track corporate actions mentioned in the text

The content includes a set of steps for tracking mergers and demergers on the Pocketful platform. It directs users to visit the Zenith Health Care Ltd stock page, navigate to the Corporate Actions section, and select the Mergers & Demergers tab. The intent of this guidance is to help users view announced, ongoing, or completed restructuring activities. No additional corporate action details are provided in the excerpt beyond the amalgamation reference and the board meeting schedule.

What to watch next, based on disclosed items

From the information available, the two key tracks are corporate restructuring and operating performance updates. On restructuring, the text confirms a board meeting schedule and the entities named in the amalgamation application, but does not confirm a final decision or timeline. On performance, the quarterly comparison indicates a move from profit to a small loss between two quarters, but without supporting line items. Any next steps would depend on subsequent official disclosures, including board outcomes, scheme documents (if filed), and more complete financial statements.